Chlorzoxazone-based One-Sample Method for Estimating In Vivo CYP2E1 Activity in Mice

Area of Science:

• Pharmacology
• Biochemistry
• Analytical Chemistry

Background:

• Cytochrome P450 2E1 (CYP2E1) is vital for drug metabolism and disease processes.
• Traditional methods for assessing in vivo CYP2E1 activity are complex and less sensitive.
• Developing a simpler, more sensitive assay for CYP2E1 activity is crucial.

Purpose of the Study:

• To develop and validate a sensitive HPLC-UV method for quantifying chlorzoxazone (CZX) and 6-hydroxy CZX (6-OH CZX) in mouse plasma.
• To establish and validate four distinct mouse models representing varying levels of CYP2E1 activity.
• To compare the sensitivity of pharmacokinetic parameters and the metabolite ratio (MR) for characterizing in vivo CYP2E1 activity.

Main Methods:

• Developed and validated an HPLC-UV method for CZX and 6-OH CZX analysis.
• Created four mouse models: high CYP2E1 activity (isoniazid), low activity (Q11 inhibitor, Cyp2e1 knockout, CCl₄).
• Analyzed pharmacokinetic parameters (t₁/₂, AUC, CL) and the 6-OH CZX/CZX ratio (MR) at different time points.

Main Results:

• The HPLC-UV method demonstrated excellent specificity, linearity, and precision.
• Established mouse models confirmed distinct CYP2E1 activity levels via in vitro assays.
• CZX half-life (t₁/₂) was more sensitive than AUC or CL for assessing CYP2E1 activity.
• The 15-minute MR showed the strongest correlation with microsomal CYP2E1 activity (r=0.57) and CZX t₁/₂ (r=0.83).

Conclusions:

• The 15-minute MR and CZX t₁/₂ provide a simplified and sensitive approach to evaluate in vivo CYP2E1 activity.
• This method overcomes limitations of traditional pharmacokinetic analyses and existing MR methods.
• The findings support the use of CZX as a probe for CYP2E1 activity, laying groundwork for future research in disease states.